LBL-034 for Injection Clinical Trials

1 actively recruiting trial

Also known as: LBL-034

Pipeline

Phase 1/2: 1

Top Sponsors

Nanjing Leads Biolabs Co.,Ltd1

Indications

Relapsed/ Refractory Multiple Myeloma1
Cancer1

Other1 trial

A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.